1. Differences in cellular uptake and cytofluorescence of Adriamycin and N-trifluoroacetyladriamycin-14-valerate;Krishan;Cancer Res,1976
2. N-Trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than Adriamycin;Israel;Cancer Res,1975
3. Comparative antineoplastic activity of Adriamycin and N-trifluoroacetyladriamycin-14-valerate;Vecchi;Cancer Treat Rep,1978
4. Comparative cardiotoxicity studies with Adriamycin (ADR) and AD 32 in rabbits (abstract);Henderson,1978
5. In vivo effects of Adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma;Potmesil;Eur J Cancer Clin Oncol,1983